首页> 外国专利> METHOD FOR DETERMINING ANTIBODIES AGAINST RETROVIRUS AND TEST EQUIPMENT, RETROVIRUS CBL-1 AND RETROVIRUS CBL-1-ANTIGENS FOR IT

METHOD FOR DETERMINING ANTIBODIES AGAINST RETROVIRUS AND TEST EQUIPMENT, RETROVIRUS CBL-1 AND RETROVIRUS CBL-1-ANTIGENS FOR IT

机译:测定抗逆转录病毒和测试设备的抗体的方法,抗逆转录病毒CBL-1和抗逆转录病毒CBL-1-抗体

摘要

Samples e.g. transfusion blood, are assayed for antibodies to retrovirus, e.g. AIDS virus, using an insolubilised antigen comprising retrovirus antigens bound to globulin, the globulin itself being bound to an inert solid support; and an immunoglobulin which contains specific antibody to the retrovirus antigens and which is labelled with a non radio active revealing label, and the liquid phase is then separated from the solid phase and the quantity of revealing label associated with either the liquid or the solid phase determined. The use of enzyme labelled antibody in competition with test sera for binding on the insolubilised antigen permits better identification of antibody containing specimens. The retroviruses may be a HTLV-I, II or III or a new retrovirus isolate CBL-1 etiologically related to AIDS.
机译:样品例如测定输血中的逆转录病毒抗体,例如AIDS病毒,使用不溶性抗原,该不溶性抗原包含与球蛋白结合的逆转录病毒抗原,球蛋白本身与惰性固体支持物结合;免疫球蛋白,其含有针对逆转录病毒抗原的特异性抗体,并用非放射性显露标记物标记,然后将液相与固相分离,并确定与液相或固相相关的显露标记物的量。使用酶标记抗体与测试血清竞争结合不溶性抗原,可以更好地鉴定含抗体的标本。逆转录病毒可以是HTLV-1,II或III或在病因上与艾滋病有关的新的逆转录病毒分离株CBL-1。

著录项

  • 公开/公告号ATA900186A

    专利类型

  • 公开/公告日1993-12-15

    原文格式PDF

  • 申请/专利权人 INSTITUTE OF CANCER RESEARCH;

    申请/专利号AT19860009001

  • 发明设计人

    申请日1986-01-13

  • 分类号G01N33/569;G01N33/577;G01N33/543;C12N7/00;

  • 国家 AT

  • 入库时间 2022-08-22 04:43:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号